A Systematic Review and Meta-Analysis on the Efficacy and Safety of Combination Therapy with Sodium-Glucose Cotransporter Type 2 Inhibitor (SGLT2i) and Dipeptidase-4 Inhibitor (DPP4i) in Treatment of Type 2 Diabetes · Peerford
Review · Journal · 2022
A Systematic Review and Meta-Analysis on the Efficacy and Safety of Combination Therapy with Sodium-Glucose Cotransporter Type 2 Inhibitor (SGLT2i) and Dipeptidase-4 Inhibitor (DPP4i) in Treatment of Type 2 Diabetes